Substanser, hvis systemiske koncentration kan ændres af nilotinib Nilotinib er en relativt stærk hæmmer af CYP3A4, CYP2C8, CYP2C9, CYP2D6 og UGT1A1 in vitro, der potentielt kan øge koncentrationerne af lægemidler, som elimineres af disse enzymer.
Substances that may have their systemic concentration altered by nilotinib Nilotinib is a relatively strong inhibitor of CYP3A4, CYP2C8, CYP2C9, CYP2D6 and UGT1A1 in vitro, potentially increasing the concentrations of substances eliminated by these enzymes.